Submitted:
04 May 2024
Posted:
06 May 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods

2.1. Plant Materials
2.1.1. Preparation Methods for Plant Extracts
2.1.2. Aqueous Extract (A)
2.1.3. Ethanolic Extract (E)
2.1.4. Enzymatic Extract (ENZ)
2.2. Screening the Phytochemical Capacity and Antioxidant Activities of Plant Extracts
2.2.1. Phytochemical Identification
- -
-
The alkaloids in plant extract were identified, using (a) the Mayer’s reagent, (b) the Wagner’s reagent and (c) the Hager’s reagent (Picric acid test) as per the previous reports.
- -
-
In summary, fifty milligrams of the extract were dissolved in 5 mL of distilled water (DW) and then filtered. Two milliliters of the resulting extract solution were transferred to a test tube containing 10 mL of benzene. The mixture was vigorously shaken for 10 minutes and then filtered. Finally, 5 mL of a 10% ammonia solution was added to the test tube and shaken vigorously for an additional 30 seconds. The presence of free anthraquinones was indicated by the development of a pink, red, or violet color, evaluated based on a positivity rating.
- -
-
Detection of terpenoidsTo detect the presence of tri-terpenoids, the Salkowski test was conducted using chloroform and concentrated sulfuric acid (H2SO4) as reagents.
- -
-
Detection of saponins (Foam test) [32]Saponins were identified by the formation of persistent foam at 25°C. To achieve this, 500 milligrams of the extract were dissolved in 2 mL of distilled water. The resulting suspension was vigorously shaken for 15 minutes in a graduated cylinder. The presence of saponins was confirmed by the formation of a 2 cm layer of foam.
- -
-
Detection of tannins (Ferric chloride test - Braymer’s test) [33]To assess tannin content, a mixture was prepared from each plant extract. This involved dissolving 500 milligrams of the extract in 5 mL of ethanol, followed by sonication at 40 kHz for 5 minutes using a sonicator, and centrifugation at 190× g for 10 minutes. Subsequently, 1 mL of supernatant was collected. Then, 1 mL of 15% ferric chloride (FeCl3) was added, and the formation of a dark green or blue-black precipitate indicated the presence of tannin.
- -
-
milligrams of the extract were dissolved in distilled water (DW) and subsequently filtered. To 2 mL of the filtrate, 1.5 mL of glacial acetic acid, a single drop of 5% ferric chloride (FeCl3), and a drop of concentrated sulfuric acid (H2SO4) along the inner walls of the test tube were added. The transition to green-blue coloration at the upper layer and reddish-brown at the interface between the two layers confirmed the presence of cardiac glycosides.
2.2.2. Total Phenolic Concentrations [34]
2.2.3. Estimation of Total Flavonoid Content
2.2.4. Total Antioxidant Activity Assay [35] (DPPH Free Radical Scavenging Assay)
2.2.5. The Reducing Power Assay
2.3. Determination of the Antibacterial Activity
2.3.1. Tested Bacterial Strains
2.3.1.1. Phenotypic Screening of Antibiotic Susceptibility Pattern of Bacterial Strains
2.3.2. 1st Assay for Evaluation of the Antibacterial Activity - Diffusion in Agar Test
2.3.3. 2nd Assay for Evaluation of the Antibacterial Activity - Determination Minimum Inhibitory Concentration and Minimum Bactericidal Concentration - Microdilution Broth Test
2.4. In Vitro Evaluation of Antibacterial Efficacies - Anti-Biofilm Properties of the Studied Herbal Extractions
2.5. Hemolytic Potential of Tested Plant Extracts in Human Erythrocytes
2.6. Statistical Analysis
3. Results
4. Discussion
4.1. Pattern of Total Phenolics and Flavonoids Content
4.2. Evaluation of Antioxidant Capacity: DPPH Assay and Ferric Reducing Assay Power (FRAP)
4.3. Antimicrobial and Anti-Biofilm Activity of the Studied Extracts
4.3.1. O. vulgare Performance
4.3.2. S. tribola Performance
4.4. Hemolytic Activity
4.5. General Aspects
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Antoniadou M, Rozos G, Vaiou N, Zaralis K, Ersanli C, Alexopoulos A, Tzora A, Varzakas T, Voidarou CC. The In Vitro Assessment of Antibacterial and Antioxidant Efficacy in Rosa damascena and Hypericum perforatum Extracts against Pathogenic Strains in the Interplay of Dental Caries, Oral Health, and Food Microbiota. Microorganisms. 2023 Dec 28;12(1):60. [CrossRef]
- Rezabakhsh A, Mahmoodpoor A, Soleimanpour H. Historical perspective of aspirin: A journey from discovery to clinical practice Ancient and modern history. J Cardiovasc Thorac Res. 2021;13(2):179-180. Epub 2021 Apr 17. [CrossRef]
- Elshafie HS, Camele I, Mohamed AA. A Comprehensive Review on the Biological, Agricultural and Pharmaceutical Properties of Secondary Metabolites Based-Plant Origin. Int J Mol Sci. 2023 Feb 7;24(4):3266. [CrossRef]
- Erb M, Kliebenstein DJ. Plant Secondary Metabolites as Defenses, Regulators, and Primary Metabolites: The Blurred Functional Trichotomy. Plant Physiol. 2020 Sep;184(1):39-52. Epub 2020 Jul 7. [CrossRef]
- Buchanan BB, Gruissem W, Jones RL, 2000, Biochemistry and Molecular Biology of Plants. Rockville, MD: American Society of Plant Phys iologists. Bob B. Buchanan (Editor), Wilhelm Gruissem (Editor), Russell L. Jones (Editor).
- Lambers, Hans & Chapin III, F Stuart & Pons, Thijs. Ecological Biochemistry: Allelopathy and Defense Against Herbivores. 2008. [CrossRef]
- Alibi S, Crespo D, Navas J. Plant-Derivatives Small Molecules with Antibacterial Activity. Antibiotics (Basel). 2021 Feb 25;10(3):231. [CrossRef]
- Bajguz, A.; Piotrowska-Niczyporuk, A. Biosynthetic Pathways of Hormones in Plants. Metabolites 2023, 13, 884. [CrossRef]
- Soltani S, Shakeri A, Iranshahi M, Boozari M. A Review of the Phytochemistry and Antimicrobial Properties of Origanum vulgare L. and Subspecies. Iran J Pharm Res. 2021 Spring;20(2):268-285. [CrossRef]
- Liang J, Luo Y, Zhao H. Synthetic biology: putting synthesis into biology. Wiley Interdiscip Rev Syst Biol Med. 2011 Jan-Feb;3(1):7-20. [CrossRef]
- Caselli E, Fabbri C, D'Accolti M, Soffritti I, Bassi C, Mazzacane S, Franchi M. Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture. BMC Microbiol. 2020 May 18;20(1):120. [CrossRef]
- Pisano, M.; Giordano, F.; Sangiovanni, G.; Capuano, N.; Acerra, A.; D’Ambrosio, F. The Interaction between the Oral Microbiome and Systemic Diseases: A Narrative Review. Microbiol. Res. 2023, 14, 1862-1878. [CrossRef]
- Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018 16(12), 745-759. [CrossRef]
- Alibi, S.; Crespo, D.; Navas, J. Plant-Derivatives Small Molecules with Antibacterial Activity. Antibiotics 2021, 10, 231. [CrossRef]
- Giordano-Kelhoffer, B.; Lorca, C.; March Llanes, J.; Rábano, A.; del Ser, T.; Serra, A.; Gallart-Palau, X. Oral Microbiota, Its Equilibrium and Implications in the Pathophysiology of Human Diseases: A Systematic Review. Biomedicines 2022, 10, 1803. [CrossRef]
- Josh L Espinoza, Manolito Torralba, Pamela Leong, Richard Saffery, Michelle Bockmann, Claire Kuelbs, Suren Singh, Toby Hughes, Jeffrey M Craig, Karen E Nelson, Chris L Dupont, Differential network analysis of oral microbiome metatranscriptomes identifies community scale metabolic restructuring in dental caries, PNAS Nexus, Volume 1, Issue 5, November 2022, pgac239. [CrossRef]
- Varzakas, T.; Antoniadou, M. A Holistic Approach for Ethics and Sustainability in the Food Chain: The Gateway to Oral and Systemic Health. Foods 2024, 13, 1224. [CrossRef]
- Cugini C, Ramasubbu N, Tsiagbe VK, Fine DH. Dysbiosis From a Microbial and Host Perspective Relative to Oral Health and Disease. Front Microbiol. 2021 Mar 5;12:617485. [CrossRef]
- Kennedy DO, Wightman EL. Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. Adv Nutr. 2011 Jan;2(1):32-50. [CrossRef]
- Chaachouay, N.; Zidane, L. Plant-Derived Natural Products: A Source for Drug Discovery and Development. Drugs Drug Candidates 2024, 3, 184-207. [CrossRef]
- Idir F, Van Ginneken S, Coppola GA, Grenier D, Steenackers HP, Bendali F. Origanum vulgare ethanolic extracts as a promising source of compounds with antimicrobial, anti-biofilm, and anti-virulence activity against dental plaque bacteria. Front Microbiol. 2022 Nov 2;13:999839. [CrossRef]
- Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MAA. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare (Basel). 2023 Jul 5;11(13):1946. [CrossRef]
- Guefack MF, Ngangoue MO, Mbaveng AT, Nayim P, Kuete JRN, Ngaffo CMN, Chi GF, Ngameni B, Ngadjui BT, Kuete V. Antibacterial and antibiotic-potentiation activity of the constituents from aerial part of Donella welwitshii (Sapotaceae) against multidrug resistant phenotypes. BMC Complement Med Ther. 2022 Jul 20;22(1):194. [CrossRef]
- Fair, Richard & Tor, Yitzhak. (2014). Antibiotics and Bacterial Resistance in the 21st Century. Perspectives in medicinal chemistry. 6. 25-64. 10.4137/PMC.S14459.
- Aljeldah, M.M. Antimicrobial Resistance and Its Spread Is a Global Threat. Antibiotics 2022, 11, 1082. [CrossRef]
- Antimicrobial Resistance Collaborators. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis. Lancet Glob Health. 2024 Feb;12(2):e201-e216. [CrossRef]
- Luepke KH, Suda KJ, Boucher H, Russo RL, Bonney MW, Hunt TD, Mohr JF 3rd. Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications. Pharmacotherapy. 2017 Jan;37(1):71-84. [CrossRef]
- Nasim N, Sandeep IS, Mohanty S. Plant-derived natural products for drug discovery: current approaches and prospects. Nucleus (Calcutta). 2022;65(3):399-411. Epub 2022 Oct 18. [CrossRef]
- Jadimurthy, R.; Jagadish, S.; Nayak, S.C.; Kumar, S.; Mohan, C.D.; Rangappa, K.S. Phytochemicals as Invaluable Sources of Potent Antimicrobial Agents to Combat Antibiotic Resistance. Life 2023, 13, 948. [CrossRef]
- Zhang QW, Lin LG, Ye WC. Techniques for extraction and isolation of natural products: a comprehensive review. Chin Med. 2018 Apr 17;13:20. [CrossRef]
- Cendrowski, A., Kraśniewska, K., Przybył, J.L., Zielińska, A., Kalisz, S. Antibacterial and Antioxidant Activity of Extracts from Rose Fruits (Rosa rugosa). Molecules 2020, 25, 1365. [CrossRef]
- Tiranakwit T, Puangpun W, Tamprasit K, Wichai N, Siriamornpun S, Srisongkram T, Weerapreeyakul N. Phytochemical Screening on Phenolic, Flavonoid Contents, and Antioxidant Activities of Six Indigenous Plants Used in Traditional Thai Medicine. Int J Mol Sci. 2023 Aug 30;24(17):13425. [CrossRef]
- Belew AA, W/Hana GG, Meshesha DS, Akele ML. Evaluation of Total Phenolic, Total Flavonoid Content And Antioxidant Activity of Rhus Vulgaris. Research Square; 2021. PPR:PPR437116. [CrossRef]
- Mabotja MB, Venter SL, Du Plooy CP, Kudanga T, Amoo SO. Phytochemical Content, Antioxidant, Alpha-Glucosidase Inhibitory and Antibacterial Activities of Spineless Cactus Pear Cultivars. Plants (Basel). 2021 Jun 28;10(7):1312. [CrossRef]
- Saeed N, Khan MR, Shabbir M. Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L. BMC Complement Altern Med. 2012, 16, 12:221. [CrossRef]
- Al-Nawas, B.; Karbach, J. S3 Leitlinie: Odontogene Infektionen. Online verfügbar unter.2017. Available Online at: https://wwwawmforg/uploads/tx_szleitlinien/007-006l_S3_Odontogene_Infektionen_2017-12pdf.
- Meinen, A, Reuss A, Willrich N.; Feig M, Noll I, Eckmanns T.; Al-Nawas B.; Markwart R. Antimicrobial Resistance and the Spectrum of Pathogens in Dental and Oral-Maxillofacial Infections in Hospitals and Dental Practices in Germany. Front Microbiol. 2021, 2, 12:676108. [CrossRef]
- Bhat, KG, Ingalagi P, Patil S, Patil S, Pattar G. Antimicrobial susceptibility pattern of oral gram negative anaerobes from Indian subjects. Anaerobe. 2021, 70, 102367. [CrossRef]
- LSI. Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard—CLSI Document M02-A11; Clinical & Laboratory Standards Institute: Wayne, PA, USA, 2015.
- CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard—Eighth Edition—CLSI Document M07-A7; Clinical & Laboratory Standards Institute: Wayne, PA, USA, 2006.
- Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2018. CLSI Supplement M100.
- The European Committee on Antimicrobial Susceptibility Testing Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth microdilution. EUCAST Discussion Document E. Def 2003, 5.1. Clin. Microbiol. Infect. 2003, 9, 1–7. [CrossRef]
- Kowalska-Krochmal B, Dudek-Wicher R. The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance. Pathogens. 2021 Feb 4;10(2):165. [CrossRef]
- Veloso DJ, Abrão F, Martins CHG, Bronzato JD, Gomes BPFA, Higino JS, Sampaio FC. Potential antibacterial and anti-halitosis activity of medicinal plants against oral bacteria. Arch Oral Biol. 2020 Feb;110:104585. [CrossRef]
- Clinical Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial a Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, 8th ed.; CLSI: Wayne, PA, USA, 2009; CLSI document M0-A8.
- Bagheri, R.; Bohlouli, S., Maleki Dizaj, S., Shahi, S., Memar, M.Y.; Salatin, S. The Antimicrobial and Anti-Biofilm Effects of Hypericum perforatum Oil on Common Pathogens of Periodontitis: An In Vitro Study. Clinics and Practice. 2022, 12, 1009–1019. [CrossRef]
- Ersanli, C.; Tzora, A.; Skoufos, I.; Fotou, K.; Maloupa, E.; Grigoriadou, K.; Voidarou, C.C.; Zeugolis, D.I. The Assessment of Antimicrobial and Anti-Biofilm Activity of Essential Oils against Staphylococcus aureus Strains. Antibiotics 2023, 12, 384. [CrossRef]
- Samreen, Qais FA, Ahmad I. Anti-quorum sensing and biofilm inhibitory effect of some medicinal plants against gram-negative bacterial pathogens: in vitro and in silico investigations. Heliyon. 2022 Oct 17;8(10):e11113. [CrossRef]
- Adeyemo RO, Famuyide IM, Dzoyem JP, Lyndy Joy M. Anti-Biofilm, Antibacterial, and Anti-Quorum Sensing Activities of Selected South African Plants Traditionally Used to Treat Diarrhoea. Evid Based Complement Alternat Med. 2022 Sep 28;2022:1307801. [CrossRef]
- Souza-Melo WO, Figueiredo-Júnior EC, Freire JCP, Costa BP, Lira AB, Freires IA, Cavalcanti YW, Lopes WS, Tavares JF, Pessôa HLF, Pereira JV. Phytochemistry, antifungal and antioxidant activity, and cytotoxicity of byrsonima gardneriana (A. Juss) extract. Arch Oral Biol. 2021 Mar;123:104994. [CrossRef]
- Sæbø, I.P.; Bjørås, M.; Franzyk, H.; Helgesen, E.; Booth, J.A. Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity. Int. J. Mol. Sci. 2023, 24, 2914. [CrossRef]
- Jiang Z, Kempinski C, Chappell J. Extraction and Analysis of Terpenes/Terpenoids. Curr Protoc Plant Biol. 2016;1:345-358. Epub 2016 Jun 10. [CrossRef]
- Knez Hrnčič, M.; Cör, D.; Simonovska, J.; Knez, Ž.; Kavrakovski, Z.; Rafajlovska, V. Extraction Techniques and Analytical Methods for Characterization of Active Compounds in Origanum Species. Molecules 2020, 25, 4735. [CrossRef]
- Skoula M and Harborne JB. The taxonomy and chemistry of Origanum. Kintzios S., medicinal and aromatic plants–industrial profiles–oregan, The genera Origanum and Lipia, Taylor & Francis: London. (2002) Aug 29: 67-108.
- Lukas B, Schmiderer C and Novak J. Phytochemical diversity of Origanum vulgare L. subsp. vulgare (Lamiaceae) from Austria. Biochem. Syst. Ecol. 2013, 50: 106-13.
- Khan M, Khan ST, Khan NA, Mahmood A, AlKedhairy AA and Alkhathlan HZ. The composition of the essential oil and aqueous distillate of Origanum vulgare L. growing in Saudi Arabia and evaluation of their antibacterial activity. Arab. J. Chem. 2018, 11: 1189-200.
- Lukas B, Schmiderer C and Novak J. Essential oil diversity of European Origanum vulgare L.(Lamiaceae). Phytochemistry 2015, 119, 32-40.
- Timothy, Chris & Priya, V. Gayathri R, Gayathri R. Phytochemical analysis and total phenolic content of Origanum vulgare (oregano). Drug Invention Today. 2018, 10. 1903-1905).
- Mróz, M., Kusznierewicz, B. Phytochemical screening and biological evaluation of Greek sage (Salvia fruticosa Mill.) extracts. Sci Rep 2023, 13, 22309. [CrossRef]
- Al-Kalaldeh, J. Z., Abu-Dahab, R. & Aff, F. U. Volatile oil composition and antiproliferative activity of Laurus nobilis, Origanum syriacum, Origanum vulgare, and Salvia triloba against human breast adenocarcinoma cells. Nutr. Res. 2010, 30(4), 271–278. [CrossRef]
- Torun, M., Dincer, C., Topuz, A., Sahin-Nadeem, H. Ozdemir, F. Aqueous extraction kinetics of soluble solids, phenolics and favonoids from sage (Salvia fruticosa Miller) leaves. J. Food Sci. Technol. 2015, 52(5), 2797–2805. [CrossRef]
- Bower, A.M.; Real Hernandez, L.M.; Berhow, M.A.; de Mejia, E.G. Bioactive Compounds from Culinary Herbs Inhibit a Molecular Target for Type 2 Diabetes Management, Dipeptidyl Peptidase IV. J. Agric. Food Chem. 2014, 62, 6147–6158.
- Jafari Khorsand, G., Morshedloo, M.R., Mumivand, H. et al. Natural diversity in phenolic components and antioxidant properties of oregano (Origanum vulgare L.) accessions, grown under the same conditions. Sci Rep 12, 5813 (2022). [CrossRef]
- Yan, Feng & Azizi, Ali & Janke, Susanne & Schwarz, Madeleine & Zeller, Stefanie & Honermeier, Bernd. (2016). Antioxidant capacity variation in the oregano (Origanum vulgare L.) collection of the German National Genebank. Industrial Crops and Products. 92. 19–25. [CrossRef]
- Özüpek, Burçin; Pekacar, Sultan; Orhan, Didem Deliorman. Evaluation of Phytochemical Contents and Biological Activities of Salvia officinalis and Salvia triloba Grown with Organic Farming FABAD Journal of Pharmaceutical Sciences; Ankara 2023, 48, 1, 125-138. [CrossRef]
- Lantzouraki DZ, Tsiaka T, Soteriou N, Asimomiti G, Spanidi E, Natskoulis P, Gardikis K, Sinanoglou VJ, Zoumpoulakis P. Antioxidant Profiles of Vitis vinifera L. and Salvia triloba L. Leaves Using High-Energy Extraction Methodologies. J AOAC Int. 2020 Apr 1;103(2):413-421. [CrossRef]
- Zhang W, Chen H, Wang Z, Lan G, Zhang L. Comparative studies on antioxidant activities of extracts and fractions from the leaves and stem of Epimedium koreanum Nakai. J Food Sci Technol. 2013 Dec;50(6):1122-9. [CrossRef]
- Indumathy, R. & Aruna, A. Free radical scavenging activities, total phenolic and flavonoid content of Lepidium sativum (Linn.). International Journal of Pharmacy and Pharmaceutical Sciences. 2013, 5. 634-637.
- Kakouri, E., Trigas, P., Daferera, D., Skotti, E., Tarantilis, P.A., Kanakis, C. Chemical Characterization and Antioxidant Activity of Nine Hypericum Species from Greece. Antioxidants 2023, 12, 899. [CrossRef]
- Jan S, Rashid M, Abd Allah EF, Ahmad P. Biological Efficacy of Essential Oils and Plant Extracts of Cultivated and Wild E.cotypes of Origanum vulgare L. Biomed Res Int. 2020, 6, 2020:8751718. [CrossRef]
- Parra, C.; Muñoz, P.; Bustos, L.; Parra, F.; Simirgiotis, M.J.; Escobar, H. UHPLC-DAD Characterization of Origanum vulgare L. from Atacama Desert Andean Region and Antioxidant, Antibacterial and Enzyme Inhibition Activities. Molecules 2021, 26, 2100. [CrossRef]
- Gülçin, Ilhami. (2015). Fe3+–Fe2+ Transformation Method: An Important Antioxidant Assay. Methods in molecular biology (Clifton, N.J.). 1208. 233-46. [CrossRef]
- Hickl J, Argyropoulou A, Sakavitsi ME, Halabalaki M, Al-Ahmad A, Hellwig E. Mediterranean herb extracts inhibit microbial growth of representative oral microorganisms and biofilm formation of Streptococcus mutans. PLoS ONE 2018, 13(12): e0207574. [CrossRef]
- Popa M, Măruțescu L, Oprea E, Bleotu C, Kamerzan C, Chifiriuc MC, Grădișteanu Pircalabioru G. In Vitro Evaluation of the Antimicrobial and Immunomodulatory Activity of Culinary Herb Essential Oils as Potential Perioceutics. Antibiotics (Basel). 2020 Jul 21;9(7):428. [CrossRef]
- Delamare, Ana Paula & Moschen-Pistorello, Ivete & Artico, Liane & Atti-Serafini, Luciana & Echeverrigaray, Sergio. (2007). Antibacterial activity of the essential oils of Salvia officinalis L. and Salvia triloba L. cultivated in South Brazil. Food Chemistry. 100. 603-608. [CrossRef]
- Eltawaty, Salwa & Busba, Abdelnaser & Omare, Mohamed-Elfatih & Almagboul, Asha & Ahmed, Sanaa Osman Yagoub & Elramli, Asma & Elnour, Asim & Dafalla, Mohammed. (2021). ANTIMICROBIAL ACTIVITY OF LIBYAN SALVIA FRUTICOSA MIL AND MULTI- DRUG RESISTANT BACTERIA. 8. 416-423.
- de Oliveira JR, Vilela PGDF, Almeida RBA, de Oliveira FE, Carvalho CAT, Camargo SEA, Jorge AOC, de Oliveira LD. Antimicrobial activity of noncytotoxic concentrations of Salvia officinalis extract against bacterial and fungal species from the oral cavity. Gen Dent. 2019, 67(1):22-26.
- Amin, Ketan & Dannenfelser, Rose. (2006). In vitro hemolysis: Guidance for the pharmaceutical scientist. Journal of pharmaceutical sciences. 95. 1173-6. [CrossRef]
- Brewer, Susan. (2011). Natural Antioxidants: Sources, Compounds, Mechanisms of Action, and Potential Applications. Comprehensive Reviews in Food Science and Food Safety. 10. 221 - 247. [CrossRef]
- Saleh, N.A.M.; El-bary, R.B.E.-d.A.; Mpingirika, E.Z.; Essa, H.L.; El-Sayed, M.M.H.; Sherbetjian, M.S.; Elfandi, H.F.; Wahed, M.A.A.; Arafeh, R.; Amleh, A. Evaluating the Potential Anticancer Properties of Salvia triloba in Human-Osteosarcoma U2OS Cell Line and Ovarian Adenocarcinoma SKOV3 Cell Line. Appl. Sci. 2022, 12, 11545. [CrossRef]
- Daniels, G. The molecular genetics of blood group polymorphism. Transplant Immunology, 2005, 14(3-4 SPEC. ISS), 143–153. [CrossRef]
- Li X, Liu Y, Yang X, Li C, Song Z. The Oral Microbiota: Community Composition, Influencing Factors, Pathogenesis, and Interventions. Front. Microbiol. 2022, 13:895537. [CrossRef]
- Silbergleit M, Vasquez AA, Miller CJ, Sun J, Kato I. Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis. Prog Mol Biol Transl Sci. 2020, 171:131-193. [CrossRef]
- Sun CH, Li BB, Wang B, Zhao J, Zhang XY, Li TT, Li WB, Tang D, Qiu MJ, Wang XC, Zhu CM, Qian ZR. The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management. Chronic Dis Transl Med. 2019, 1;5(3):178-187. [CrossRef]
- Lemos JA, Palmer SR, Zeng L, Wen ZT, Kajfasz JK, Freires IA, Abranches J, Brady LJ. The Biology of Streptococcus mutans. Microbiol Spectr. 2019 Jan;7(1):10.1128/microbiolspec.GPP3-0051-2018. [CrossRef]
- Matsumoto-Nakano M. Role of Streptococcus mutans surface proteins for biofilm formation. Jpn Dent Sci Rev. 2018 Feb;54(1):22-29. [CrossRef]
- Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018 16(12), 745-759. [CrossRef]
- Löwenmark T, Li X, Löfgren-Burström A, Zingmark C, Ling A, Kellgren TG, Larsson P, Ljuslinder I, Wai SN, Edin S, Palmqvist R. Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer. Cancer Immunol Immunother. 2022 Oct;71(10):2565-2575. [CrossRef]
- Pignatelli P, Nuccio F, Piattelli A, Curia MC. The Role of Fusobacterium nucleatum in Oral and Colorectal Carcinogenesis. Microorganisms. 2023 Sep 20;11(9):2358. [CrossRef]
- Kerdreux M, Edin S, Löwenmark T, Bronnec V, Löfgren-Burström A, Zingmark C, Ljuslinder I, Palmqvist R, Ling A. Porphyromonas gingivalis in Colorectal Cancer and its Association to Patient Prognosis. J Cancer. 2023 May 21;14(9):1479-1485. [CrossRef]
- Aladhadh, M. A Review of Modern Methods for the Detection of Foodborne Pathogens. Microorganisms 2023, 11, 1111. [CrossRef]
- Shakil MH, Trisha AT, Rahman M, Talukdar S, Kobun R, Huda N, Zzaman W. Nitrites in Cured Meats, Health Risk Issues, Alternatives to Nitrites: A Review. Foods. 2022 Oct 25;11(21):3355. [CrossRef]
- Redondo-Blanco S, Fernández J, López-Ibáñez S, Miguélez EM, Villar CJ, Lombó F. Plant Phytochemicals in Food Preservation: Antifungal Bioactivity: A Review. J Food Prot. 2020 Jan;83(1):163-171. [CrossRef]
- Dominguez LJ, Veronese N, Vernuccio L, Catanese G, Inzerillo F, Salemi G, Barbagallo M. Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia. Nutrients. 2021 Nov 15;13(11):4080. [CrossRef]
- Wong, Young & Chow, Yit-Lai. (2023). Exploring the potential of spice-derived phytochemicals as alternative antimicrobial agents. eFood. 5. [CrossRef]
- Teshome, S., Jaleta,A., Jemal, M., Abamecha, A., Gershe, S. Phytochemical screening and evaluation of antimicrobial activity of Pterolobium stellatum root extract. Pharm Pharmacol Int J. 2023;11(4):151‒156. https://medcraveonline.com/PPIJ/PPIJ-11-00413.pdf.
- Siddiqui SA, Khan S, Mehdizadeh M, Bahmid NA, Adli DN, Walker TR, Perestrelo R, Câmara JS. Phytochemicals and bioactive constituents in food packaging - A systematic review. Heliyon. 2023 Oct 24;9(11):e21196. [CrossRef]
- Bouarab Chibane, L., Degraeve, P., Ferhout, H., Bouajila, J. and Oulahal, N. (2019), Plant antimicrobial polyphenols as potential natural food preservatives. J. Sci. Food Agric., 99: 1457-1474. [CrossRef]
- Thakur, Monika & Singh, Karuna & Khedkar, Renu. (2020). Phytochemicals. [CrossRef]
- Lombrea A, Antal D, Ardelean F, Avram S, Pavel IZ, Vlaia L, Mut AM, Diaconeasa Z, Dehelean CA, Soica C, Danciu C. A Recent Insight Regarding the Phytochemistry and Bioactivity of Origanum vulgare L. Essential Oil. Int J Mol Sci. 2020 Dec 17;21(24):9653. [CrossRef]
- Prado L, Zalba M, Amato D. Sustainability in Oral Health: The Role of Natural Products. Molecules. 2020, 25(10):2267. [CrossRef]
- Souza LGA, Lopes LGC, Hill MP, Harries P, Eggersdorfer M, Marušić K. Sustainable Sourcing of Plant-Based Ingredients for Oral Health Care. Nutrients. 2021;13(3):1002. [CrossRef]






| Isolate | Source | Characterization based on Gram staining |
Oxygen requirements for growth/ Growth conditions used in the present study |
| Streptococcus mutans | Oral cavity | Gram+ | Facultatively anaerobic/ Growth under anaerobic conditions |
| Streptococcus salivarius | Oral cavity | Gram+ | Facultatively anaerobic/ Growth under anaerobic conditions |
| Fusobacterium nucleatum | Oral cavity | Gram- | Obligate anaerobic / Growth under anaerobic conditions |
| Porphyromonas gingivalis | Oral cavity | Gram- | Obligate anaerobic / Growth under anaerobic conditions |
| Prevotella intermedia | Oral cavity | Gram- | Obligate anaerobic/ Growth under anaerobic conditions |
| Parvimonas micra | Oral cavity | Gram+ | Obligate anaerobic / Growth under anaerobic conditions |
| Staphylococcus aureus, Methicillin, and vancomycin resistant | Dental caries area | Gram+ | Best in the presence of oxygen-rich environment/ Growth under aerobic conditions |
| Methicillin-Resistant S. aureus | Raw milk | Gram+ | Best in the presence of oxygen-rich environment/ Growth under aerobic conditions |
| Methicillin-Resistant S. aureus | Poultry meat | Gram+ | Best in the presence of oxygen-rich environment/ Growth under aerobic conditions |
|
Staphylococcus aureus subsp. aureus |
Reference strain ATCC 6538 | ||
| Phytochemical compounds | Plants extracts | |||||||
|---|---|---|---|---|---|---|---|---|
| Origanum vulgare | Salvia triloba | |||||||
| A | Ε40 | Ε60 | ΕΝΖ | A | Ε40 | Ε60 | ΕΝΖ | |
| Alkaloids | + | - | - | + | + | - | - | - |
| Anthraquinones | - | - | - | + | + | - | - | - |
| Terpenoids (Salkowski’s test) | + | + | + | + | + | + | + | + |
| Steroids | + | - | - | + | - | - | - | - |
| Saponins | - | + | + | - | + | + | - | - |
| Flavonoids (alkaline reagent test) | + | + | + | + | + | + | + | + |
| Tannins (ferric chloride test) | + | + | + | - | + | + | + | + |
| Glycosides (Keller-Kiliani test) | + | + | + | + | + | + | + | - |
| Plant extracts | Total phenolics (mg gallic acid equivalent/g of dried sample) | Total Flavonoids (mg catechin equivalent per /g of dried sample) |
|---|---|---|
| Oregano A | 39.69±0.54b | 8.13±0.82a |
| Oregano A* | 45.46±0.8c | 15.9±0.38b |
| Oregano E40 | 76.68±3.34e | 22.56±0.48c |
| Oregano E60 | 88.44±0.6f | 30.74±0.98d |
| Oregano ENZ | 121.4±0.6g | 48.83±1.17f |
| Salvia A | 91.99±1.08f | 55.31±0.35g |
| Salvia A* | 79±0.8e | 37.58±1.15e |
| Salvia E40 | 50.76±0.6d | 37.56±0.47e |
| Salvia E60 | 22.44±0.6a | 39.67±0.44e |
| Salvia ENZ | 90.42±0.5f | 64.75±0.65h |
| Plant extracts | Concentration (μg/ml) | |||||
|---|---|---|---|---|---|---|
| 1 | 10 | 50 | 100 | 300 | 500 | |
| Oregano A | 3,42±0,33bc | 10,57±0,13c | 33,34±0,58b | 38,55±0,21b | 52,24±0,22a | 59,32±0,85a |
| Oregano A* | 5,28±0,1d | 12,18±0,42d | 40,86±0,02e | 45,26±0,53c | 59,52±0,4b | 62,92±0,35b |
| Oregano E40 | 4,12±0,11cf | 12,19±0,23d | 50,46±0,34g | 70,48±0,07g | 74,5±0,39e | 77,33±0,11d |
| Oregano E60 | 12,37±0,28g | 18,06±0,19f | 55,24±0,21h | 76,79±0,22h | 80,7±0,17f | 81,36±0,25e |
| Oregano ENZ | 11,6±0,45ef | 14,32±0,34e | 57,99±0,22i | 78,77±0,17i | 82,44±0,42g | 86,43±0,42g |
| Salvia A | 11,5±0,39e | 14,12±0,12e | 39,53±0,45d | 60,53±0,33f | 82,21±0,32g | 84,24±0,29f |
| Salvia A* | 3,42±0,16bc | 9,36±0,27b | 32,38±0,44b | 48,43±0,34d | 80,13±0,29f | 82,38±0,44e |
| Salvia E40 | 2,63±0,2b | 10,22±0,19c | 35,27±0,22c | 48,36±0,39d | 72,37±0,26d | 74,49±0,42c |
| Salvia E60 | 1,37±0,41a | 6,33±0,25a | 22,38±0,41a | 30,31±0,23a | 54,97±0,44b | 60,53±0,41a |
| Salvia ENZ | 12,71±0,24g | 17,37±0,42f | 42,73±0,25f | 59,25±0,18e | 85,46±0,21h | 87,14±0,71g |
| Plant extracts | Concentration (μg/ml) | |||||
|---|---|---|---|---|---|---|
| 2.5 | 5 | 10 | 15 | 20 | 25 | |
| Oregano A | 0.15±0a | 0,21±0a | 0.31±0a | 0.57±0a | 0.77±0a | 0.85±0a |
| Oregano A* | 0.21±0c | 0,40±0c | 0.55±0f | 0.81±0c | 1.01±0c | 1.21±0d |
| Oregano E40 | 0.22±0d | 0,49±0g | 0.75±0h | 1.28±0h | 1.44±0g | 1.62±0f |
| Oregano E60 | 0.24±0c | 0,55±0h | 0.83±0i | 1.34±0i | 1.55±0h | 1.77±0g |
| Oregano ENZ | 0.23±0c | 0,58±0i | 0.99±0j | 1.48±0j | 1.65±0i | 1.93±0i |
| Salvia A | 0.24±0c | 0,37±0d | 0.44±0bc | 0.78±0d | 0.98±0d | 1.33±0c |
| Salvia A* | 0.18±0b | 0,32±0c | 0.54±0f | 0.71±0c | 0.86±0bc | 1.11±0c |
| Salvia E40 | 0.19±0b | 0,31±0c | 0.48±0d | 0.68±0b | 0.85±0b | 1.09±0b |
| Salvia E60 | 0.18±0b | 0,28±0b | 0.38±0b | 0.70±0c | 0.85±0b | 1.08±0b |
| Salvia ENZ | 0.26±0f | 0,38±0d | 0.51±0c | 0.88±0f | 1.31±0f | 1.76±0g |
| Reference | ||||||
| Gallic acid (GA) | 0.18±0.0b | 0.43±0f | 1.81±0k | 1.85±0k | 1.88±0j | 1.88±0h |
| Ascorbic acid (AA) | 0.19±0.0b | 0.42±0f | 0.68±0g | 1.12±0g | 1.65±0i | 1.88±0h |
| Pathogen | Disk Content (%) | A(mm) | E40(mm) | E60(mm) | Enz(mm) |
|---|---|---|---|---|---|
| S. aureus MRSA/VRSA | 10 | 6±0.1a | 7.5±0.5a | 9.7±0.6ab | 11.5±0.4d |
| 20 | 13.8±0.8ef | 10±0.6ab | 14.7±0.5b | 15±0.5e | |
| 50 | 15.7±0.5ab | 16.2±0.6b | 18.3±0.7a | 19.1±1.1b | |
| 100 | 18.1±0.3ab | 19.3±0.6bc | 21±0.1b | 22.4±0.1b | |
| MRSA (raw milk) | 10 | 6.5±0.3a | 8.4±0.3a | 10.8±0.6bc | 8.7±0.5ab |
| 20 | 10.8±0.3bc | 10.4±0.3ab | 15.1±0.4b | 15.3±0.9e | |
| 50 | 9.7±6.8a | 14.1±0.1a | 17.6±0.5a | 19±0.9b | |
| 100 | 18.2±0.4ab | 17.5±0.5a | 18.8±0.6a | 20.4±0.4ab | |
| MRSA (raw poultry) | 10 | 6.9±0.1a | 9.8±0.6bc | 12.2±0.2d | 8±0.5a |
| 20 | 11.5±0.4de | 13.2±0.6de | 18.5±0.3c | 15.1±0.4e | |
| 50 | 22.9±5.2b | 19.5±0.3d | 27.8±0.9d | 18.7±0.5b | |
| 100 | 19.2±0.4cd | 26.5±0.6d | 38.7±0.8f | 22.1±0.5b | |
| S. mutans | 10 | 9.6±0.7c | 8.1±0.3a | 12.1±0.8c | 9.5±0.4b |
| 20 | 12.6±0.4de | 11.2±0.6ab | 19.3±0.5de | 12.4±0.2bc | |
| 50 | 17.1±0.4ab | 17.3±0.6cd | 28.6±0.9d | 18.8±0.3b | |
| 100 | 19.8±0.5cd | 19.8±0.4bc | 31.4±0.6e | 22.3±2.7b | |
| S. salivarius | 10 | 6.2±0.2a | 8.1±0.2a | 10.7±0.5b | 7.7±0.6a |
| 20 | 9.8±0.3ab | 11.8±0.3bcd | 18.5±0.7cd | 11.5±0.5ab | |
| 50 | 15.2±0.4ab | 15.9±0.4b | 25±0.4c | 17±0.1b | |
| 100 | 19±0.3cd | 20.7±1.3c | 28.2±0.5c | 19.6±0.5ab | |
| P. gingivalis | 10 | 8.6±0.5bc | 10.7±0.5cd | 12.3±0.4d | 9.7±0.5bc |
| 20 | 13.5±0.4ef | 14.8±0.1e | 19.5±0.6de | 14.1±0.7de | |
| 50 | 18.2±0.5b | 19.5±0.3d | 29±0.3d | 19±0.3b | |
| 100 | 20.6±0.7d | 19.9±0.1bc | 31.1±0.2e | 21.8±0.4b | |
| F. nucleatum | 10 | 6.1±0.2a | 7.9±0.2a | 13.3±0.2d | 10.1±0.2c |
| 20 | 8.9±0.6a | 14.8±0.2e | 19.1±0.2de | 13.8±0.5cd | |
| 50 | 15.3±0.5ab | 18.1±0.7cd | 28.2±0.5d | 18.7±0.7b | |
| 100 | 17.8±0.5ab | 20.2±0.3c | 32.5±1.5ef | 21.9±0.3b | |
| P. intermedia | 10 | 6.1±0.1a | 8.6±0.4ab | 10.6±0.2b | 8.4±0.7a |
| 20 | 12.5±0.4ef | 12.4±0.5cd | 17.2±0.5c | 11.2±0.8a | |
| 50 | 16.8±0.5ab | 17.1±0.3bc | 21.9±1.8b | 18.1±0.2b | |
| 100 | 18.8±0.3abc | 19.1±0bc | 29.3±0.6b | 21.9±0.7b | |
| P. micra | 10 | 6.3±0.6a | 11.7±0.5d | 12.6±0.6d | 9.6±0.5b |
| 20 | 14.8±0.4f | 18.2±0.4f | 20±0.2e | 13.3±0.2cd | |
| 50 | 16.9±0.4ab | 24.2±1.1e | 27.9±0.4d | 18±0.2b | |
| 100 | 18.2±0.2ab | 31.4±0.4e | 31.1±0.1e | 20.6±0.4ab | |
| S. aureus ATCC 12600 (Ref) | 10 | 8.3±0.5b | 8.1±0.6a | 9.1±0.1a | 10.2±0.3c |
| 20 | 12.8±0.5de | 12.5±1.3c | 12.3±0.6a | 13±0.3bc | |
| 50 | 16.6±0.4ab | 17.4±0.6bc | 18±0.3a | 17.8±0.4ab | |
| 100 | 17.6±0.5a | 19.1±0.2bc | 18.7±0.5a | 19.2±0.4a |
| Pathogen | Disk Content (%) | A(mm) | E40(mm) | E60(mm) | Enz(mm) |
|---|---|---|---|---|---|
| S. aureus MRSA/VRSA | 10 | 6.7±0.6ab | 10±0.7cd | 10.5±0.5abc | 6±0a |
| 20 | 11.3±0.4bc | 12.6±0.2cd | 15±0.4bc | 8.5±0.6a | |
| 50 | 13.4±0.4ac | 17.5±0.5cd | 18.9±0.5bc | 12.2±0.3a | |
| 100 | 17.6±0.3abc | 18.5±0.3bc | 22.8±2ab | 17.9±0.4a | |
| MRSA (raw milk) | 10 | 7.6±0.6ab | 12.5±0.4e | 12.6±0.3d | 7.4±0.5b |
| 20 | 11.9±0.7bc | 15±0.2e | 18.6±0.3ef | 12±0.4c | |
| 50 | 14.8±0.5bc | 18±0.3d | 23.2±0.6e | 14.6±0.2b | |
| 100 | 17.6±0.3abc | 24.3±0.4e | 28.7±0.6c | 17.4±0.4a | |
| MRSA (raw poultry) | 10 | 6.4±0.4a | 9.1±0.7ab | 11.4±0.7bcd | 7.8±0.5bc |
| 20 | 10.6±0.1bc | 10.6±0.2a | 16.2±0.6cd | 10.7±0.4b | |
| 50 | 14.9±0.2bc | 16.2±0.3bc | 20.6±0.5cd | 15.2±0.4bc | |
| 100 | 17.4±0.4bc | 18.3±0.6abc | 29.1±0.8c | 17.7±0.3a | |
| S. mutans | 10 | 10.8±0.8de | 8.6±0.3ab | 9.8±0.4a | 12.1±0.5e |
| 20 | 16.4±0.4f | 10.7±0.3ab | 11.9±0.5a | 17.1±0.2cd | |
| 50 | 20.7±0.8g | 15.2±0.3ab | 16.7±0.5ab | 21.5±0.7e | |
| 100 | 29.3±0.9f | 16.7±0.2a | 18.5±0.5a | 30.8±0.6b | |
| S. salivarius | 10 | 8.4±0.8bc | 10.8±0.6de | 11.7±0.4cd | 9.3±0.3d |
| 20 | 12.9±0.6de | 13.1±0.8d | 17.4±0.5de | 12.8±0.5b | |
| 50 | 16.4±0.5de | 16.3±0.5bc | 22.2±0.7de | 17.8±0.3d | |
| 100 | 18.5±0.6cd | 18.5±0.5bc | 27.5±5.5bc | 18.5±0.4a | |
| P. gingivalis | 10 | 11.2±0.8e | 7.6±0.5a | 10.2±0.2ab | 12.2±0.6e |
| 20 | 15.2±0.5f | 11.9±0.3c | 14±0.7b | 18.2±0.3de | |
| 50 | 20.6±0.5fg | 14.1±0.3a | 17±0.2ab | 28.1±1g | |
| 100 | 32.3±1.9g | 17.5±0.3ab | 18.6±0.4a | 33.8±1.2cd | |
| F. nucleatum | 10 | 6.1±0.1a | 9.8±0.4bcd | 11.9±0.6cd | 9.8±0.4d |
| 20 | 9.3±0.6a | 10.4±0.4a | 17.2±0.2de | 16.7±0.4c | |
| 50 | 12.4±0.6a | 13.9±0.2a | 24.1±1.4e | 19.6±0.8d | |
| 100 | 16±0.2b | 16.8±0.2a | 28.9±0.9c | 30.3±0.8b | |
| P. intermedia | 10 | 9.6±0.2cde | 8.3±0.6ab | 11.7±0.5cd | 9±0.1cd |
| 20 | 13.7±0.2e | 12±0.4c | 19±0.4f | 12.5±0.7b | |
| 50 | 19±0.2ef | 17.3±0.4cd | 28.4±0.6f | 16.7±0.4cd | |
| 100 | 24.5±0.5e | 19.1±0.8c | 31.7±0.6c | 17.9±0.1a | |
| P. micra | 10 | 9.5±0.6cd | 10.6±0.6cd | 11±0.5abc | 12±0.5e |
| 20 | 12.4±0.4de | 15.3±0.5e | 16.2±0.3cd | 19.3±0.5e | |
| 50 | 17.8±0.9de | 21.6±1.2e | 20.8±0.5de | 29.3±0.5f | |
| 100 | 21.2±0.9d | 27.8±1.1f | 30.9±0.3c | 35.4±1.1d | |
| S. aureus ATCC 12600 (Ref) | 10 | 9.4±0.5cd | 10.9±1.1de | 10.5±0.6abc | 11.1±0.1e |
| 20 | 12.9±0.5de | 14.9±0.1e | 18.1±0.6ef | 18±0.2de | |
| 50 | 17.5±0.6de | 18.3±1d | 26.7±0.7f | 22.2±1e | |
| 100 | 19.8±0.4cd | 21±0.4d | 30.7±0.4c | 31.8±2bc |
| Minimum Inhibitory Concentration (mg/mL) |
Minimum Bactericidal Concentration (mg/mL) |
|||||||
|---|---|---|---|---|---|---|---|---|
| Pathogen | A | E40 | E60 | Enz | A | E40 | E60 | Enz |
| S. aureus MRSA/VRSA | 6.3±0b | 3.1±0b | 1.6±0b | 1.6±0b | 12.5±0b | 6.3±0c | 3.1±0b | 1.6±0a |
| MRSA (raw milk) | 6.3±0b | 6.3±0 | 3.1±0c | 3.1±0c | 12.5±0b | 12.5±0 | 12.5±0d | 6.3±0c |
| MRSA (raw poultry) | 3.1±0a | 0.8±0a | 0.4±0a | 0.8±0a | 6.3±0a | 1.6±0a | 1.6±0a | 1.6±0a |
| S. mutans | 3.1±0b | 3.1±0b | 1.6±0b | 3.1±0c | 6.3±0a | 12.5±0d | 3.1±0b | 6.3±0c |
| S. salivarius | 6.3±0b | 3.1±0b | 1.6±0b | 3.1±0c | 12.5±0b | 6.3±0c | 6.3±0c | 6.3±0c |
| P. gingivalis | 6.3±0b | 6.3±0c | 1.6±0b | 0.8±0a | 25±0c | 12.5±0d | 3.1±0b | 6.3±0c |
| F. nucleatum | 6.3±0b | 3.1±0b | 0.8±0a | 3.1±0c | 25±0c | 12.5±0d | 3.1±0b | 3.1±0b |
| P. intermedia | 6.3±0b | 3.1±0b | 0.8±0a | 3.1±0c | 25±0c | 12.5±0d | 6.3±0c | 12.5±0d |
| P. micra | 12.5±0c | 0.8±0a | 0.8±0a | 1.6±0b | 25±0c | 3.1±0b | 6.3±0c | 6.3±0c |
| S. aureus ATCC 12600 (Ref) | 6.3±0b | 3.1±0b | 3.1±0c | 1.6±0b | 12.5±0b | 12.5±0d | 12.5±0d | 6.3±0c |
| Minimum Inhibitory Concentration (mg/mL) |
Minimum Bactericidal Concentration (mg/mL) |
|||||||
|---|---|---|---|---|---|---|---|---|
| Pathogen | A | E40 | E60 | Enz | A | E40 | E60 | Enz |
| S. aureus MRSA/VRSA | 12.5±0e | 3.1±0b | 1.6±0b | 6.3±0d | 50±0d | 12.5±0c | 6.3±0d | 25±0f |
| MRSA (raw milk) | 6.3±0d | 3.1±0b | 1.6±0b | 6.3±0d | 12.7±0.3b | 12.5±0c | 3.1±0c | 25±0f |
| MRSA (raw poultry) | 12.5±0e | 6.3±0c | 0.8±0a | 3.1±0c | 50±0d | 12.5±0c | 3.1±0c | 12.5±0e |
| S. mutans | 0.8±0a | 6.3±0c | 3.1±0c | 0.8±0a | 6.3±0a | 25±0d | 12.5±0d | 3.1±0c |
| S. salivarius | 3.1±0c | 3.1±0b | 0.8±0a | 6.3±0d | 12.7±0.3b | 6.3±0b | 1.6±0b | 12.5±0 |
| P. gingivalis | 0.8±0a | 6.3±0c | 6.3±0d | 0.8±0a | 6.3±0a | 25±0d | 12.5±0d | 1.6±0b |
| F. nucleatum | 12.5±0 | 6.3±0c | 1.6±0b | 1.6±0b | 50±0d | 12.5±0c | 3.1±0c | 1.6±0b |
| P. intermedia | 1.6±0b | 3.1±0b | 0.8±0a | 3.1±0c | 12.7±0.3b | 12.5±0c | 0.8±0a | 6.3±0d |
| P. micra | 1.6±0b | 1.6±0a | 0.8±0a | 0.4±0a | 6.3±0a | 3.1±0a | 0.8±0a | 1.6±0b |
| S. aureus ATCC 12600 (Ref) | 6.3±0d | 1.6±0a | 0.8±0a | 0.7±0.2a | 25±0c | 3.1±0a | 3.1±0c | 0.8±0a |
| Concentration of each plant extract (μg/mL) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12.5 | 25 | 50 | 100 | 150 | 200 | 250 | 500 | 1000 | |
| Oregano A | 4.35±11de | 4.21±0.61bc | 4.46±0.71cde | 5.45±0.31bc | 7.57±0.32c | 8.45±0.123c | 8.64±0.123bcd | 9.37±0.234ab | 10.1±0.54ab |
| Oregano A* | 2.74±0.51bc | 3.81±0.71bc | 4.54±0.612de | 6.04±0.72bcd | 9.04±0.73d | 10.43±0.534c | 11.34±0.74cde | 19.9±0.95c | 21.62±0.45cd |
| Oregano E40 | 3.55±0.11cd | 4.1±0.912bc | 4.17±0.912cd | 7.03±1.412cd | 9.07±0.712d | 14.42±3.323d | 21.51±1.63f | 34.39±2.64d | 54.92±9.75e |
| Oregano E60 | 4.94±0.61de | 6.07±0.41d | 6.62±0.51f | 9.04±1.11a | 10.68±0.31e | 22.14±1.22ce | 29.09±13g | 31.76±0.53d | 82.58±5.94f |
| Oregano ENZ | 0.55±0.41a | 1.43±0.51a | 1.94±0.11ab | 4.5±0.112b | 7.24±0.22c | 8.01±0.52 | 14.38±4.13e | 29.42±0.24d | 31.1±0.54 |
| Salvia A | 0.88±0.21ab | 1.32±0.112a | 1.9±0.123ab | 2.49±0.23a | 2.89±0.34a | 4.06±0.45ab | 4.76±0.65ab | 6.29±0.36a | 7.46±0.37a |
| Salvia A* | 1.39±0.41a | 1.61±0.31a | 3.04±0.72bc | 4.46±0.33b | 5.67±0.34b | 7.1±0.55bc | 8.23±0.56abc | 9.04±0.167a | 9.59±0.17ab |
| Salvia E40 | 2.6±0.31bc | 3.33±0.112b | 3.81±0.212cd | 4.9±0.412b | 5.74±0.4123b | 7.24±0.2123bc | 8.6±0.223bcd | 6.41±5.63a | 10.76±0.23ab |
| Salvia E60 | 3.77±0.31cde | 4.87±0.412cd | 5.63±0.22ef | 7.32±0.134de | 8.12±0.84cd | 10.06±15c | 12.99±0.96e | 14.89±0.47bc | 19.72±0.88bc |
| Salvia ENZ | 0.18±0.31a | 0.8±0.112a | 0.91±0.112a | 1.24±0.12a | 2.56±0.53a | 3.11±0.234a | 3.92±0.34a | 5.89±0.65a | 7.98±0.76a |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).